Tandem Diabetes Care Stock Price, News & Analysis (NASDAQ:TNDM)

$2.92 0.11 (3.91 %)
(As of 01/18/2018 02:31 PM ET)
Previous Close$2.81
Today's Range$2.61 - $3.00
52-Week Range$2.15 - $30.00
Volume896,300 shs
Average Volume1.22 million shs
Market Capitalization$28.94 million
P/E Ratio-0.15
Dividend YieldN/A
Beta0.17

About Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Receive TNDM News and Ratings via Email

Sign-up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorHealthcare
SymbolNASDAQ:TNDM
CUSIPN/A
Phone+1-858-3666900

Debt

Debt-to-Equity Ratio-2.70%
Current Ratio1.90%
Quick Ratio0.88%

Price-To-Earnings

Trailing P/E Ratio-0.148148148148148
Forward P/E Ratio-0.19
P/E GrowthN/A

Sales & Book Value

Annual Sales$84.25 million
Price / Sales0.35
Cash FlowN/A
Price / CashN/A
Book Value($1.90) per share
Price / Book-1.54

Profitability

Trailing EPS($19.71)
Net Income$-83,440,000.00
Net Margins-79.45%
Return on EquityN/A
Return on Assets-74.29%

Miscellaneous

Employees591
Outstanding Shares10,120,000

Tandem Diabetes Care (NASDAQ:TNDM) Frequently Asked Questions

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

When did Tandem Diabetes Care's stock split? How did Tandem Diabetes Care's stock split work?

Tandem Diabetes Care shares reverse split on the morning of Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, October 9th 2017. An investor that had 100 shares of Tandem Diabetes Care stock prior to the reverse split would have 10 shares after the split.

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care Inc (NASDAQ:TNDM) announced its quarterly earnings data on Thursday, October, 26th. The medical device company reported ($3.09) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($3.74) by $0.65. The medical device company earned $27 million during the quarter, compared to analyst estimates of $25.92 million. The firm's quarterly revenue was up 119.7% on a year-over-year basis. During the same period last year, the company posted ($0.97) earnings per share. View Tandem Diabetes Care's Earnings History.

When will Tandem Diabetes Care make its next earnings announcement?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Thursday, March, 1st 2018. View Earnings Estimates for Tandem Diabetes Care.

Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2018?

6 Wall Street analysts have issued 12-month target prices for Tandem Diabetes Care's shares. Their forecasts range from $3.00 to $17.00. On average, they anticipate Tandem Diabetes Care's share price to reach $13.00 in the next year. View Analyst Ratings for Tandem Diabetes Care.

Who are some of Tandem Diabetes Care's key competitors?

Who are Tandem Diabetes Care's key executives?

Tandem Diabetes Care's management team includes the folowing people:

  • Dick P. Allen, Independent Chairman of the Board (Age 72)
  • Kim D. Blickenstaff, President, Chief Executive Officer, Director (Age 64)
  • Leigh Vosseller, Chief Financial Officer, Senior Vice President
  • John F. Sheridan, Chief Operating Officer, Executive Vice President (Age 61)
  • David B. Berger Esq., Executive Vice President, General Counsel, Secretary (Age 47)
  • Brian B. Hansen, Chief Commercial Officer, Executive Vice President (Age 49)
  • Susan M. Morrison, Chief Administrative Officer (Age 37)
  • Edward L. Cahill, Independent Director (Age 61)
  • Fred E. Cohen Ph.D. M.D., Independent Director (Age 60)
  • Howard E. Greene Jr., Independent Director (Age 74)

Who owns Tandem Diabetes Care stock?

Tandem Diabetes Care's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Wasatch Advisors Inc. (2.75%). Company insiders that own Tandem Diabetes Care stock include Dick Allen, John F Sheridan and Kim D Blickenstaff. View Institutional Ownership Trends for Tandem Diabetes Care.

Who sold Tandem Diabetes Care stock? Who is selling Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc.. View Insider Buying and Selling for Tandem Diabetes Care.

How do I buy Tandem Diabetes Care stock?

Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tandem Diabetes Care's stock price today?

One share of Tandem Diabetes Care stock can currently be purchased for approximately $2.92.

How big of a company is Tandem Diabetes Care?

Tandem Diabetes Care has a market capitalization of $28.94 million and generates $84.25 million in revenue each year. The medical device company earns $-83,440,000.00 in net income (profit) each year or ($19.71) on an earnings per share basis. Tandem Diabetes Care employs 591 workers across the globe.

How can I contact Tandem Diabetes Care?

Tandem Diabetes Care's mailing address is 11045 Roselle St Ste 200, SAN DIEGO, CA 92121-1231, United States. The medical device company can be reached via phone at +1-858-3666900 or via email at [email protected]


MarketBeat Community Rating for Tandem Diabetes Care (TNDM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  162 (Vote Outperform)
Underperform Votes:  195 (Vote Underperform)
Total Votes:  357
MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tandem Diabetes Care (NASDAQ:TNDM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.332.332.442.44
Ratings Breakdown: 0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
4 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $13.00$13.00$32.43$50.83
Price Target Upside: 343.69% upside343.69% upside5,480.55% upside425.63% upside

Tandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History

Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/19/2017Robert W. BairdReiterated RatingHold$3.00N/AView Rating Details
10/10/2017WedbushReiterated RatingOutperform$50.00 -> $17.00N/AView Rating Details
10/6/2017Piper Jaffray CompaniesReiterated RatingHold$15.00N/AView Rating Details
5/3/2017B. RileyReiterated RatingNeutral$15.00MediumView Rating Details
4/10/2017CowenDowngradeOutperform -> Market Perform$15.00MediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche BankLower Price TargetBuy$140.00 -> $90.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
11/2/2016Stifel NicolausDowngradeBuy -> Hold$150.00 -> $35.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
3/24/2016Bank of AmericaDowngradeNeutral -> UnderperformN/AView Rating Details
(Data available from 1/18/2016 forward)

Earnings

Tandem Diabetes Care (NASDAQ:TNDM) Earnings History and Estimates Chart

Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2018($2.45)N/AView Earnings Details
10/26/2017Q3 2017($3.74)($3.09)$25.92 million$27.00 millionViewN/AView Earnings Details
7/27/2017Q2 2017($4.80)($4.40)$21.74 million$21.30 millionViewN/AView Earnings Details
4/27/2017Q1 2017($6.60)($7.50)$15.72 million$17.50 millionViewN/AView Earnings Details
3/8/2017Q4 2016($6.50)($4.80)$22.75 million$24.80 millionViewListenView Earnings Details
11/1/2016Q3 2016($5.90)($9.70)ViewN/AView Earnings Details
7/28/2016Q216($6.50)($6.00)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($6.90)($6.80)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($5.10)($4.00)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($8.00)($6.50)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($7.10)($6.50)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($7.90)($8.30)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($8.10)($7.80)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($8.20)($8.50)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($9.10)($8.30)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($6.90)($9.60)$8.24 million$8.10 millionViewN/AView Earnings Details
3/6/2014Q4 2013($13.10)($16.00)ViewN/AView Earnings Details
11/8/2011$2.50$1.80ViewN/AView Earnings Details
8/9/2011$2.60$2.00ViewN/AView Earnings Details
5/10/2011$2.40$2.40ViewN/AView Earnings Details
3/14/2011$2.90$1.80ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Tandem Diabetes Care (NASDAQ:TNDM) Earnings Estimates

2018 EPS Consensus Estimate: ($1.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.34)($0.34)($0.34)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.28)($0.28)($0.28)
Q4 20182($0.28)($0.20)($0.24)
(Earnings estimates data provided by Zacks Investment Research)

Dividends

Dividend History for Tandem Diabetes Care (NASDAQ:TNDM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Tandem Diabetes Care (NASDAQ TNDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 20.90%
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/13/2017Kim D BlickenstaffCEOBuy285,700$3.50$999,950.00View SEC Filing  
3/23/2017Kim D BlickenstaffCEOBuy1,600,000$1.25$2,000,000.002,007,939View SEC Filing  
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.0022,763View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.007,295View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.007,295View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.009,295View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.004,084View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.004,084View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.004,084View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tandem Diabetes Care (NASDAQ TNDM) News Headlines

Source:
DateHeadline
BRIEF-Tandem Diabetes Care Files For Offering Of Up To $40 MlnBRIEF-Tandem Diabetes Care Files For Offering Of Up To $40 Mln
www.reuters.com - January 16 at 11:09 AM
34 Stocks Moving In Wednesdays Mid-Day Session34 Stocks Moving In Wednesday's Mid-Day Session
feeds.benzinga.com - January 10 at 12:57 PM
Tandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 GuidanceTandem Diabetes Care Announces Preliminary 2017 Results and Provides 2018 Guidance
finance.yahoo.com - January 10 at 11:13 AM
Tandem Diabetes (TNDM) Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump - StreetInsider.comTandem Diabetes (TNDM) Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump - StreetInsider.com
www.streetinsider.com - January 8 at 3:55 PM
Tandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study TimelineTandem Diabetes Care Reports Successful Completion of First Pilot Study Using t:slim X2 Insulin Pump with TypeZero Hybrid Closed Loop Technology and Dexcom G6 Integration; Confirms IDCL Multi-site Study Timeline
finance.yahoo.com - January 8 at 3:55 PM
Tandem Diabetes Care Inc (TNDM) Given Average Recommendation of "Hold" by BrokeragesTandem Diabetes Care Inc (TNDM) Given Average Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - January 8 at 8:38 AM
Tandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment ResearchTandem Diabetes Care (TNDM) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - January 6 at 7:02 AM
Tandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Downgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - January 5 at 2:02 PM
Tandem Diabetes Care Commences Full Manufacturing Operations at New San Diego FacilityTandem Diabetes Care Commences Full Manufacturing Operations at New San Diego Facility
finance.yahoo.com - January 3 at 10:38 AM
Head to Head Comparison: Bio-Rad Laboratories (BIO) versus Tandem Diabetes Care (TNDM)Head to Head Comparison: Bio-Rad Laboratories (BIO) versus Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - December 31 at 9:30 AM
New Year to Bring Back MedTech Tax, 3 Stocks Unfazed - NasdaqNew Year to Bring Back MedTech Tax, 3 Stocks Unfazed - Nasdaq
www.nasdaq.com - December 27 at 11:49 AM
New Year to Bring Back MedTech Tax, 3 Stocks UnfazedNew Year to Bring Back MedTech Tax, 3 Stocks Unfazed
finance.yahoo.com - December 27 at 11:49 AM
Zacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Post Quarterly Sales of $34.36 MillionZacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Post Quarterly Sales of $34.36 Million
www.americanbankingnews.com - December 27 at 6:12 AM
Tandem Diabetes Care Inc (TNDM) Expected to Post Earnings of -$1.30 Per ShareTandem Diabetes Care Inc (TNDM) Expected to Post Earnings of -$1.30 Per Share
www.americanbankingnews.com - December 25 at 1:16 PM
Tandem Diabetes Care (TNDM) and Landauer (LDR) Critical ComparisonTandem Diabetes Care (TNDM) and Landauer (LDR) Critical Comparison
www.americanbankingnews.com - December 23 at 5:32 AM
Tandem Diabetes Care (TNDM) Raised to "Buy" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - December 20 at 5:56 PM
Where Tandem Diabetes Care Inc (NASDAQ:TNDM) Stands In Terms Of Earnings Growth Against Its IndustryWhere Tandem Diabetes Care Inc (NASDAQ:TNDM) Stands In Terms Of Earnings Growth Against Its Industry
finance.yahoo.com - December 19 at 3:49 PM
Comparing Palomar Medical Technologies (PMTI) & Tandem Diabetes Care (TNDM)Comparing Palomar Medical Technologies (PMTI) & Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - December 16 at 9:32 AM
Tandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery TechnologyTandem Diabetes Care Announces Issuance of Patent Related to Automated Insulin Delivery Technology
finance.yahoo.com - December 14 at 11:22 AM
Tandem Diabetes Care Inc (TNDM) Receives Average Rating of "Hold" from AnalystsTandem Diabetes Care Inc (TNDM) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - December 14 at 8:42 AM
Tandem Diabetes Care (TNDM) Downgraded by Zacks Investment Research to HoldTandem Diabetes Care (TNDM) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - December 13 at 10:20 AM
Tandem Diabetes Care (TNDM) Upgraded to "Buy" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - December 10 at 6:28 AM
Zacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Announce Quarterly Sales of $34.36 MillionZacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Announce Quarterly Sales of $34.36 Million
www.americanbankingnews.com - December 9 at 2:44 AM
Tandem Diabetes Care Announces Retirement of CFO and ... - Business Wire (press release)Tandem Diabetes Care Announces Retirement of CFO and ... - Business Wire (press release)
www.businesswire.com - December 8 at 11:26 AM
Tandem Diabetes Care Announces Retirement of CFO and Successor AppointmentTandem Diabetes Care Announces Retirement of CFO and Successor Appointment
finance.yahoo.com - December 8 at 11:26 AM
-$1.30 Earnings Per Share Expected for Tandem Diabetes Care Inc (TNDM) This Quarter-$1.30 Earnings Per Share Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - December 7 at 9:36 PM
ETFs with exposure to Tandem Diabetes Care, Inc. : November 29, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : November 29, 2017
finance.yahoo.com - November 29 at 3:50 PM
$34.36 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter$34.36 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter
www.americanbankingnews.com - November 22 at 1:46 PM
Tandem Diabetes Care, Inc. (TNDM) PT Lowered to $2.00 at Bank of America CorporationTandem Diabetes Care, Inc. (TNDM) PT Lowered to $2.00 at Bank of America Corporation
www.americanbankingnews.com - November 20 at 2:52 PM
Reviewing Zimmer Biomet Holdings (ZBH) and Tandem Diabetes Care (TNDM)Reviewing Zimmer Biomet Holdings (ZBH) and Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - November 20 at 1:30 AM
 Analysts Anticipate Tandem Diabetes Care, Inc. (TNDM) Will Announce Earnings of -$1.30 Per Share Analysts Anticipate Tandem Diabetes Care, Inc. (TNDM) Will Announce Earnings of -$1.30 Per Share
www.americanbankingnews.com - November 20 at 1:28 AM
Tandem Diabetes Care, Inc. (TNDM) Rating Reiterated by Robert W. BairdTandem Diabetes Care, Inc. (TNDM) Rating Reiterated by Robert W. Baird
www.americanbankingnews.com - November 19 at 7:36 PM
Tandem Diabetes Care, Inc. (TNDM) Receives Consensus Recommendation of "Hold" from BrokeragesTandem Diabetes Care, Inc. (TNDM) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 19 at 7:54 AM
Tandem Diabetes Care to Present at the 29th Annual Piper Jaffray Healthcare ConferenceTandem Diabetes Care to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 18 at 9:31 AM
ETFs with exposure to Tandem Diabetes Care, Inc. : November 17, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : November 17, 2017
finance.yahoo.com - November 18 at 9:31 AM
Tandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference - Business Wire (press release)Tandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference - Business Wire (press release)
www.businesswire.com - November 9 at 8:17 AM
Tandem Diabetes Care to Present at the Stifel 2017 Healthcare ConferenceTandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference
finance.yahoo.com - November 7 at 8:33 PM
ETFs with exposure to Tandem Diabetes Care, Inc. : November 6, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 12:11 PM
Human Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump with Automated Insulin Delivery FeatureHuman Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump with Automated Insulin Delivery Feature
finance.yahoo.com - November 5 at 7:32 AM
Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration,Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration,
www.nasdaq.com - November 2 at 9:56 AM
Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - November 2 at 9:56 AM
$35.30 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter$35.30 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter
www.americanbankingnews.com - November 1 at 1:54 PM
Tandem Diabetes Care, Inc. (TNDM) Stock Rating Upgraded by Zacks Investment ResearchTandem Diabetes Care, Inc. (TNDM) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - November 1 at 11:56 AM
Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 9:45 AM
 Analysts Expect Tandem Diabetes Care, Inc. (TNDM) to Announce -$2.65 EPS Analysts Expect Tandem Diabetes Care, Inc. (TNDM) to Announce -$2.65 EPS
www.americanbankingnews.com - October 30 at 1:24 PM
Tandem Diabetes Cares (TNDM) CEO Kim Blickenstaff on Q3 2017 Results - Earnings Call TranscriptTandem Diabetes Care's (TNDM) CEO Kim Blickenstaff on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - October 28 at 2:42 AM
Tandem Diabetes Care EPS of -$3.09Tandem Diabetes Care EPS of -$3.09
seekingalpha.com - October 27 at 4:31 PM
ETFs with exposure to Tandem Diabetes Care, Inc. : October 27, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 4:30 PM
Tandem Diabetes Care, Inc. (TNDM) Issues Quarterly  Earnings ResultsTandem Diabetes Care, Inc. (TNDM) Issues Quarterly Earnings Results
www.americanbankingnews.com - October 27 at 3:40 PM
Tandem Diabetes Care Reports Third Quarter 2017 Financial Results - Business Wire (press release)Tandem Diabetes Care Reports Third Quarter 2017 Financial Results - Business Wire (press release)
www.businesswire.com - October 27 at 6:57 AM

SEC Filings

Tandem Diabetes Care (NASDAQ:TNDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tandem Diabetes Care (NASDAQ:TNDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tandem Diabetes Care (NASDAQ TNDM) Stock Chart for Thursday, January, 18, 2018

Loading chart…

This page was last updated on 1/18/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.